4-(5-(4-(dimethylamino)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)-4,5-dihydro-1H-pyrazol-1-ylsulfonyl)benzonitrile

ID: ALA4847141

PubChem CID: 164608990

Max Phase: Preclinical

Molecular Formula: C29H32N6O2S

Molecular Weight: 528.68

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(C3=NN(S(=O)(=O)c4ccc(C#N)cc4)C(c4ccc(N(C)C)cc4)C3)cc2)CC1

Standard InChI:  InChI=1S/C29H32N6O2S/c1-32(2)25-10-8-24(9-11-25)29-20-28(23-6-12-26(13-7-23)34-18-16-33(3)17-19-34)31-35(29)38(36,37)27-14-4-22(21-30)5-15-27/h4-15,29H,16-20H2,1-3H3

Standard InChI Key:  CVJMRJWJUWVRHC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   27.5162  -27.3924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2261  -26.9879    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   27.5209  -26.5754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4508  -28.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1112  -28.9077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7743  -28.4299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5226  -27.6498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.7063  -27.6513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5483  -28.6847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7147  -29.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4903  -29.7409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1002  -29.1956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9292  -28.3922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1538  -28.1410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6742  -28.6761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0686  -28.1258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2913  -28.3755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1184  -29.1751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7290  -29.7245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5040  -29.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3408  -29.4263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7344  -28.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1697  -30.2254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8769  -29.4494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0405  -30.2538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8133  -30.5084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4246  -29.9655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.2577  -29.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4796  -28.9065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2004  -30.2223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5600  -26.2435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3703  -26.1628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7042  -25.4192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2262  -24.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4107  -24.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0805  -25.5868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5596  -24.0108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8901  -23.2639    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6  9  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  4 15  1  0
 18 21  1  0
 21 22  1  0
 21 23  1  0
 12 24  1  0
  8  2  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
  2 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 34 37  1  0
 37 38  3  0
M  END

Alternative Forms

  1. Parent:

    ALA4847141

    ---

Associated Targets(Human)

HCC1806 (544 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 528.68Molecular Weight (Monoisotopic): 528.2307AlogP: 3.92#Rotatable Bonds: 6
Polar Surface Area: 83.25Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.83CX LogP: 4.43CX LogD: 3.86
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.48Np Likeness Score: -1.66

References

1. Chen CH, Jiang Y, Wu R, Tang Y, Wan C, Gao H, Mao Z..  (2021)  Discovery of heterocyclic substituted dihydropyrazoles as potent anticancer agents.,  48  [PMID:34214509] [10.1016/j.bmcl.2021.128233]

Source